Literature DB >> 23327924

Inflammatory neovascularization during graft-versus-host disease is regulated by αv integrin and miR-100.

Franziska Leonhardt1, Sebastian Grundmann, Martin Behe, Franziska Bluhm, Rebecca A Dumont, Friederike Braun, Melpomeni Fani, Katarina Riesner, Gabriele Prinz, Anne-Kathrin Hechinger, Ulrike V Gerlach, Heide Dierbach, Olaf Penack, Annette Schmitt-Gräff, Jürgen Finke, Wolfgang A Weber, Robert Zeiser.   

Abstract

Acute graft-versus-host disease (GvHD) is a complex process involving endothelial damage and neovascularization. Better understanding of the pathophysiology of neovascularization during GvHD could help to target this process while leaving T-cell function intact. Under ischemic conditions, neovascularization is regulated by different micro RNAs (miRs), which potentially play a role in inflamed hypoxic GvHD target organs. We observed strong neovascularization in the murine inflamed intestinal tract (IT) during GvHD. Positron emission tomography imaging demonstrated abundant αvβ3 integrin expression within intestinal neovascularization areas. To interfere with neovascularization, we targeted αv integrin-expressing endothelial cells, which blocked their accumulation in the IT and reduced GvHD severity independent of immune reconstitution and graft-versus-tumor effects. Additionally, enhanced neovascularization and αv integrin expression correlated with GvHD severity in humans. Expression analysis of miRs in the inflamed IT of mice developing GvHD identified miR-100 as significantly downregulated. Inactivation of miR-100 enhanced GvHD indicating a protective role for miR-100 via blocking inflammatory neovascularization. Our data from the mouse model and patients indicate that inflammatory neovascularization is a central event during intestinal GvHD that can be inhibited by targeting αv integrin. We identify negative regulation of GvHD-related neovascularization by miR-100, which indicates common pathomechanistic features of GvHD and ischemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23327924     DOI: 10.1182/blood-2012-07-442665

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.

Authors:  Parvathi Ranganathan; Apollinaire Ngankeu; Nina C Zitzer; PierPaolo Leoncini; Xueyan Yu; Lucia Casadei; Kishore Challagundla; Dawn K Reichenbach; Sabrina Garman; Amy S Ruppert; Stefano Volinia; Jessica Hofstetter; Yvonne A Efebera; Steven M Devine; Bruce R Blazar; Muller Fabbri; Ramiro Garzon
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

Review 2.  Biomarkers for posttransplantation outcomes.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2018-04-05       Impact factor: 22.113

3.  Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

Authors:  Shernan G Holtan; Michael R Verneris; Kirk R Schultz; Laura F Newell; Gabrielle Meyers; Fiona He; Todd E DeFor; Gregory M Vercellotti; Arne Slungaard; Margaret L MacMillan; Sarah A Cooley; Bruce R Blazar; Angela Panoskaltsis-Mortari; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-07       Impact factor: 5.742

Review 4.  Immune modulatory effects of statins.

Authors:  Robert Zeiser
Journal:  Immunology       Date:  2018-02-20       Impact factor: 7.397

5.  Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.

Authors:  Ran Reshef; Alex Ganetsky; Edward P Acosta; Robin Blauser; Lisa Crisalli; Jessica McGraw; Noelle V Frey; Elizabeth O Hexner; James A Hoxie; Alison W Loren; Selina M Luger; James Mangan; Edward A Stadtmauer; Rosemarie Mick; Robert H Vonderheide; David L Porter
Journal:  Biol Blood Marrow Transplant       Date:  2018-10-10       Impact factor: 5.742

6.  Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset.

Authors:  Jan Hülsdünker; Katja J Ottmüller; Hannes P Neeff; Motoko Koyama; Zhan Gao; Oliver S Thomas; Marie Follo; Ali Al-Ahmad; Gabriele Prinz; Sandra Duquesne; Heide Dierbach; Susanne Kirschnek; Tim Lämmermann; Martin J Blaser; Brian T Fife; Bruce R Blazar; Andreas Beilhack; Geoffrey R Hill; Georg Häcker; Robert Zeiser
Journal:  Blood       Date:  2018-02-20       Impact factor: 22.113

7.  A distinct glycerophospholipid metabolism signature of acute graft versus host disease with predictive value.

Authors:  Yue Liu; Aijie Huang; Qi Chen; Xiaofei Chen; Yang Fei; Xiaoming Zhao; Weiping Zhang; Zhanying Hong; Zhenyu Zhu; Jianmin Yang; Yifeng Chai; Jianmin Wang; Xiaoxia Hu
Journal:  JCI Insight       Date:  2019-07-25

8.  Biomarkers for fatal immune response to stem cell treatment could reduce mortality.

Authors:  Sophie Paczesny
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

9.  MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.

Authors:  Nina C Zitzer; Katiri Snyder; Xiamoei Meng; Patricia A Taylor; Yvonne A Efebera; Steven M Devine; Bruce R Blazar; Ramiro Garzon; Parvathi Ranganathan
Journal:  J Immunol       Date:  2018-05-02       Impact factor: 5.422

10.  Extracellular vesicles as potential biomarkers of acute graft-vs-host disease.

Authors:  G Lia; L Brunello; S Bruno; A Carpanetto; P Omedè; M Festuccia; L Tosti; E Maffini; L Giaccone; M Arpinati; G Ciccone; M Boccadoro; A Evangelista; G Camussi; B Bruno
Journal:  Leukemia       Date:  2017-08-30       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.